← Evidence map

ArticleDrug design, development and therapy2009

T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.

Thomas H Waid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 19920935